Publication | Open Access
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors
140
Citations
19
References
2021
Year
NCT02881190.
| Year | Citations | |
|---|---|---|
Page 1
Page 1